“A Risk Factor in the Development of Hepatocellular Carcinoma: Insulin Analogues”. Annals of Medical Research 29, no. 11 (November 23, 2022): 1209–1213. Accessed April 7, 2025. http://annalsmedres.org/index.php/aomr/article/view/4328.